Nice article Dave
There is a whole economic / financial side to Cancer treatment ( well any health care treatments for that matter )
This is not to overlook the life disrupting regimes that these treatment programs cause for the patients & their families .
leave aside the question of effectiveness of the B Cell Platform , C 33 & Oncaralytics
Thats another discussion - BUT SEEMS LIKE ALL x3 PLATFORMS COULD BE NO BRAINERS !!!! ... as indicative info to date implies effectiveness at a similar level to the current SoC ( Thats certainly seems to be the case with the B cell Platform ...and rumours seem to indicate its going to be the case with C 33 ) - Side effects ???? ....bugger all by the sounds of it
....... lets look at the costs of treating a cancer patient
Who pays for the costs ?
a) People who have really good insurance
b) People who are pretty well off and can round up $100 k - $500 k
c) People who aren't that well off ...and maybe need to send themselves bankrupt paying for the exceptionally expensive regimes
c) Government health care programs ..... ( and just how much can government afford to pay etc etc
Where do the costs go ?
a) A stack to the Big Pharma companies
b) A stack to the health care providers ( Treatment times in facilities , hospitalisations , after care , day patients , etc etc etc
What sort of disruption is it to the Patients life , and the family / support groups around that patient
> I'l let people discuss that .... but doesn't need a lot of imagination ...as anyone whos had
sick family mmembers of freinds will know !!!
In summary - The costs are frikking astronomical !!!!
>
>
>
So enter the B Cell Platform & C 33
> Apparently minimaal costs of Direct production
> Apparently minimal costs of administration
> Apparently minimal costs of treatment regime
> Apparently little disruptive costs to the patient's & family life
So now segway to the Insurance industry & Govenment health services
The economics of the B Cell Platform & C33 ....could be akin to the economics of LED lights --- ie providing the same Lumen Output at a about 20% of the power consumption
Note this could be a bit of a naive assessment on my part ..... and skeptics might say " we have no proof yet " ----- but there in lies the opportunity with IMU
It looks like a pretty good risk reward scenario ...and especially so at these levels
GLTAH
DYOR
https://www.npr.org/sections/health...te calculated,Usually, most costs are covered.
https://www.cancercouncil.com.au/re...hat the,considerable variation by cancer type.
- Forums
- ASX - By Stock
- Media Thread
Nice article Dave There is a whole economic / financial side to...
-
- There are more pages in this discussion • 5,864 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.2¢ |
Change
-0.002(3.70%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.2¢ | $148.9K | 2.828M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 2436853 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 392814 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 2436853 | 0.052 |
43 | 4493294 | 0.051 |
58 | 4676760 | 0.050 |
19 | 2213068 | 0.049 |
20 | 815580 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 392814 | 5 |
0.054 | 3612717 | 13 |
0.055 | 870851 | 7 |
0.056 | 2745820 | 14 |
0.057 | 859484 | 10 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online